Cost-Offsets of New Medications for Treatment of Schizophrenia
Year of publication: |
October 2006
|
---|---|
Authors: | Frank, Richard G. |
Other Persons: | Normand, Sharon-Lise (contributor) ; McGuire, Thomas G. (contributor) |
Institutions: | National Bureau of Economic Research (contributor) |
Publisher: |
Cambridge, Mass : National Bureau of Economic Research |
Subject: | Innovation | Gesundheitskosten | Health care costs | Arzneimittel | Pharmaceuticals |
Extent: | 1 Online-Ressource |
---|---|
Series: | NBER working paper series ; no. w12643 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Mode of access: World Wide Web System requirements: Adobe [Acrobat] Reader required for PDF files Hardcopy version available to institutional subscribers. |
Other identifiers: | 10.3386/w12643 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995 - 2010
Lichtenberg, Frank, (2015)
-
Lichtenberg, Frank R., (2014)
-
The long-term impact of price controls in medicare part D
Moreno, Gigi, (2017)
- More ...
-
Real Output in Mental Health Care During the 1990s
Berndt, Ernst R., (2005)
-
Cost-offset of new medications for treatment of schizophrenia
Frank, Richard G., (2006)
-
Using elicitation techniques to estimate the value of ambulatory treatments for major depression
Normand, Sharon-Lise T., (2002)
- More ...